This is a preview of subscription content, log in via an institution to check access.
Notes
2019 US dollars
Reference
Jiang Y, et al. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US Advances in Therapy : 19 Apr 2021. Available from: URL: https://doi.org/10.1007/s12325-021-01701-1
Rights and permissions
About this article
Cite this article
Sugammadex budget saving for reversal of neuromuscular blockade. PharmacoEcon Outcomes News 877, 21 (2021). https://doi.org/10.1007/s40274-021-7670-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7670-7